1. White HS, Woodhead JH, Wilcox KS, Stables JP, Kupferberg HJ, Wolf HH. Discovery and preclinical development of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic drugs. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002: 36–48.
2. White HS, Woodhead JH, Franklin MR, Swinyard EA, Wolf HH. General principles: experimental selection, quantification, and evaluation of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press, Ltd.; 1995: 99–110.
3. White HS, Wolf HH, Woodhead JH, Kupferberg HJ. The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. In: French J, Leppik I, Dichter MA, eds. Antiepileptic drug development: advances in neurology. Vol. 76. Philadelphia: Lippincott-Raven; 1998: 29–39.
4. Kupferberg H. Animal models used in the screening of antiepileptic drugs. Epilepsia 2001;42(suppl 4): 7–12.
5. Stables JP, Bertram E, Dudek FE, et al. Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 2003;44: 1472–1478.